Tag: SamAltman

Browse our exclusive articles!

Tech Mahindra CEO accepts challenge to build ChatGPT-like tool, says Sam Altman is taken out of context

OpenAI's founder, Sam Altman, clarifies his comments on Tech Mahindra CEO's challenge to develop an AI tool to rival ChatGPT. Altman believes Indian start-ups can come up with something new.

China’s Vital Role in Establishing AI Safety on a Global Scale: Urgent Request from OpenAI’s CEO

Learn about the crucial role China plays in shaping AI safety measures. OpenAI's CEO Sam Altman urges for collaboration, despite hurdles, to benefit global AI innovation and governance.

PM Modi welcomes collaborations to accelerate digital transformation after meeting OpenAI CEO

Indian Prime Minister Narendra Modi and OpenAI CEO Sam Altman have discussed India's potential to benefit from AI and collaborations in digital transformation. Altman stressed the need for self-regulation and partnering with organizations to determine testing limits. With Altman on a six-nation tour, India's entrepreneurial spirit and start-ups were praised. Discover more in the article!

ChatGPT Maker OpenAI Stays Private to Make Unconventional Choices

OpenAI CEO, Sam Altman, has confirmed that the company will not go public to avoid conflicts of interest and maintain control over the development of AI tech. Altman is currently visiting Europe, the Middle East, and Asia to work with regulators on frameworks to mitigate potential harm. He has also called for more regulation in Washington, citing a significant harm possibility caused by AI.

OpenAI CTO’s Twitter Account Hacked, Promotes Scam Airdrop.

OpenAI's CTO, Mita Murati's Twitter account was hacked, promoting a scam crypto airdrop. Social media security is now of significant concern. #OpenAI #TwitterHack #SocialMediaSecurity

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img